Weiss Asset Management’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-80,000
Closed -$19.6M – 758
2026
Q2
$19.6M Buy
+80,000
New +$17.3M 0.21% 82
2019
Q2
– Sell
-11,999
Closed -$171K – 356
2019
Q1
$171K Buy
+11,999
New +$111K 0.01% 231

Other funds holding AXSM

Weiss Asset Management's AXSM Position: Q3 2026 in Review

Weiss Asset Management sold out of Axsome Therapeutics (AXSM) in Q3 2026, closing a stake of 80,000 shares — an estimated $19.6M sold.

Weiss Asset Management first reported a position in AXSM in Q1 2019 and held it in 2 quarters. The position peaked at $19.6M in Q2 2026. 466 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.

  • Weiss Asset Management reported no remaining Axsome Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Weiss Asset Management sold 80,000 Axsome Therapeutics shares in Q3 2026, an estimated $19.6M.
  • Weiss Asset Management first reported a position in Axsome Therapeutics in Q1 2019 and held it in 2 quarters.
  • Weiss Asset Management's Axsome Therapeutics position peaked at $19.6M in Q2 2026.
  • 466 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.

Based on Weiss Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.